For general education only. This information does not diagnose a condition or replace medical advice. Your provider will determine which evaluation or treatment is appropriate for you.
Identify the concern first
Desire, arousal, pain, dryness, and satisfaction are distinct experiences. Care may involve reviewing medicines, addressing a condition, counseling, comfort measures, or a prescription when appropriate. Pain or bleeding may need an examination.
Mechanisms do not establish suitability
Medicines may act through different pathways, including signaling involved in sexual response or blood flow. A proposed mechanism does not show that a medicine will help every woman or every concern.
Bremelanotide has a specific approved indication and eligibility criteria. Other options listed on Lola may involve off label use or compounded preparations. Ask about the evidence for your exact concern and the exact product rather than assuming every listing is approved for women’s sexual symptoms.
Approval and evidence matter
FDA approval applies to a specific product, formulation, indication, and population. Off label use means an approved medicine is prescribed outside its approved labeling. A compounded preparation is not FDA approved and has not undergone the same premarket review for safety, effectiveness, and quality.
Your provider should explain the strength and limitations of the evidence, alternatives, and important risks or interactions. Do not combine sexual wellness medicines or adjust a prescription yourself.
Define meaningful follow up
Discuss what improvement would mean to you, how adverse effects will be monitored, and when to reassess. There is no guaranteed change in desire or sexual experience.
Questions to bring
- Which concern does this option address?
- What evidence supports this use in women?
- What risks and medicine interactions should we discuss?
- Would an examination or a nonmedication approach be more appropriate?